tirzepatide and hormone replacement therapy Body weight reduction in women treated with by reproductive stage: a post hoc analysis from the SURMOUNT program - Tchang - 2025 - Obesity Menopause, Tirzepatide & HRT: The

Similarly, over a 12-month period, 417% of insulin-treated patients reported needing assistance and 3764% experienced any hypoglycemic symptoms

Conclusions Twenty-four weeks of acarbose monotherapy in newly diagnosed patients with T2D is associated with significantly increased levels of both fasting and postprandial GLP-1 as well as significantly increased NO levels and NOS activity for those patients in whom postprandial GLP-1 levels were increased

Interesting to see Menu-Order-AI highlighted as part of a new category: medication-aware dining

One firm plans to make a semaglutide jab at a starting price of 1,290 rupees a month Read more at The Business Times.

Stomach discomfort from GLP-1 medications like semaglutide is common but manageable